In vivo lysogenization of a Clostridium difficile bacteriophage ΦCD119

被引:24
|
作者
Govind, Revathi [1 ,2 ]
Fralick, Joe A. [2 ]
Rolfe, Rial D. [2 ]
机构
[1] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA
[2] Texas Tech Univ Hlth Sci Ctr, Dept Microbiol & Immunol, Lubbock, TX 79430 USA
关键词
Clostridium difficile; Bacteriophage; Lysogenization; MOLECULAR CHARACTERIZATION; TOXIN SYNTHESIS; GENOME; STRAINS; PATHOGENICITY; ANTIBIOTICS; EVOLUTION; INFECTION; PHAGES; GENE;
D O I
10.1016/j.anaerobe.2011.05.012
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clostridium difficile is a nosocomial pathogen identified as the cause of antibiotic-associated diarrhea and colitis. In this study, we have documented the lysogeny of a C difficile bacteriophage in hamsters during C difficile infection. The lysogens isolated from the hamsters were toxin typed and their phage integration site was confirmed by PCR Through toxin ELISA it was found that the toxin production in the in vivo isolated lysogens was affected due to Phi CD119 lysogenization as in the case of in vitro isolated Phi CD119 lysogens. Together our findings indicate that a baceriophage can lysogenize its C difficile host even during the infection process and highlights the importance of lysogeny of C difficile phages as an evolutionary adaptation for survival. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 50 条
  • [1] Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains
    Nale, Janet Y.
    Shan, Jinyu
    Hickenbotham, Peter T.
    Fawley, Warren N.
    Wilcox, Mark H.
    Clokie, Martha R. J.
    PLOS ONE, 2012, 7 (05):
  • [2] Prevention of Clostridium difficile-induced ileocecitis with bacteriophage
    Ramesh, V
    Fralick, JA
    Rolfe, RD
    ANAEROBE, 1999, 5 (02) : 69 - 78
  • [3] Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo
    Nale, Janet Y.
    Spencer, Janice
    Hargreaves, Katherine R.
    Buckley, Anthony M.
    Trzepinski, Przemyslaw
    Douce, Gillian R.
    Clokie, Martha R. J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) : 968 - 981
  • [4] Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system
    Meader, Emma
    Mayer, Melinda J.
    Gasson, Michael J.
    Steverding, Dietmar
    Carding, Simon R.
    Narbad, Arjan
    ANAEROBE, 2010, 16 (06) : 549 - 554
  • [5] Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system
    Meader, Emma
    Mayer, Melinda J.
    Steverding, Dietmar
    Carding, Simon R.
    Narbad, Arjan
    ANAEROBE, 2013, 22 : 25 - 30
  • [6] Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model
    Nale, Janet Y.
    Redgwell, Tamsin A.
    Millard, Andrew
    Clokie, Martha R. J.
    ANTIBIOTICS-BASEL, 2018, 7 (01): : 1 - 15
  • [7] Evidence of In Vivo Prophage Induction during Clostridium difficile Infection
    Meessen-Pinard, Mathieu
    Sekulovic, Ognjen
    Fortier, Louis-Charles
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2012, 78 (21) : 7662 - 7670
  • [8] Bacteriophage-Mediated Toxin Gene Regulation in Clostridium difficile
    Govind, Revathi
    Vediyappan, Govindsamy
    Rolfe, Rial D.
    Dupuy, Bruno
    Fralick, Joe A.
    JOURNAL OF VIROLOGY, 2009, 83 (23) : 12037 - 12045
  • [9] Lipoprotein CD0873 Is a Novel Adhesin of Clostridium difficile
    Kovacs-Simon, Andrea
    Leuzzi, Rosanna
    Kasendra, Magdalena
    Minton, Nigel
    Titball, Richard W.
    Michell, Stephen L.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (02) : 274 - 284
  • [10] Global Transcriptional Response of Clostridium difficile Carrying the φCD38-2 Prophage
    Sekulovic, Ognjen
    Fortier, Louis-Charles
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2015, 81 (04) : 1364 - 1374